Gene therapy offers new hope for thalassemia patients in Pakistan

Pakistan is on the verge of a historic medical breakthrough in the treatment of the life-threatening disease thalassemia, as the country prepares to introduce its first-ever gene therapy. The revolutionary treatment is expected to offer new hope to thousands of patients who currently depend on lifelong blood transfusions for survival.

Renowned UK-based Pakistani gene therapist Dr. Sher Bahadur Anjum stated that gene therapy has the potential to eliminate the need for regular blood transfusions after treatment.

 He explained that this advanced medical approach enables thalassemia patients to lead healthy and normal lives, marking a major shift in the management of the disease.

According to Dr. Anjum, gene therapy is not merely a treatment but a long-term solution that addresses the root cause of thalassemia at the genetic level.

He described the development as a milestone for Pakistan’s healthcare system and a turning point for families affected by the condition.

In recognition of his outstanding services for humanity and his significant contributions toward improving the lives of thalassemia patients, a special award ceremony is being organized in London. The event is being jointly hosted by Professional Relief Organization (PRO) and Amina Bashir Memorial Thalassemia Trust (ABMT).

Organizers stated that Dr. Sher Bahadur Anjum will be honored for his dedication, innovation, and commitment to bringing advanced gene therapy solutions closer to Pakistani patients.

Health experts believe this initiative is not only a medical achievement but also a beacon of hope for a healthier and brighter future for children in Pakistan suffering from thalassemia.